trustmebro.to/r/…
✓ checked
trust me, bro:
here is the receipt.
the claim

Atypical hemolytic uremic syndrome is diagnosed through characteristic clinical and laboratory findings

the verdict
SUPPORTED
the evidence backs this
Recorded sources
7 sources for · 0 against

Counts group repeated records of the same source within each side. They do not measure evidence strength or source independence.

Is it true that Atypical hemolytic uremic syndrome is diagnosed through characteristic clinical and laboratory findings?

Yes. Atypical hemolytic uremic syndrome is diagnosed through a combination of characteristic clinical presentations, laboratory markers of microangiopathic hemolytic anemia and thrombocytopenia, and specialized complement or genetic evaluations.

Verdict: SUPPORTED · 7 sources for, 0 against · Last checked

The analysis

Multiple papers discuss the diagnostic criteria for atypical hemolytic uremic syndrome (aHUS), confirming that it is diagnosed using characteristic clinical presentations (such as organ injury and hypertension) and laboratory findings (such as microangiopathic hemolytic anemia, thrombocytopenia, elevated LDH, and complement abnormalities). No papers refute this claim.

Evidence for · 7
Atypical Hemolytic Uremic Syndrome, Genetic Basis, and Clinical Manifestations
2011
Identifies aHUS as a disease of complement activation with specific clinical manifestations and genetic bases.
Get citation
Kavanagh, D. & Goodship, T. H. J. (2011). Atypical Hemolytic Uremic Syndrome, Genetic Basis, and Clinical Manifestations. doi.org. https://doi.org/10.1182/asheducation-2011.1.15

See more details
More for · 6
Atypical hemolytic uremic syndrome: from diagnosis to treatment
2015
Lists key presenting symptoms of thrombotic microangiopathies including aHUS, such as microangiopathic hemolytic anemia, thrombocytopenia, and organ damage.
Get citation
Franchini, M. (2015). Atypical hemolytic uremic syndrome: from diagnosis to treatment. doi.org. https://doi.org/10.1515/cclm-2015-0024

Update in the diagnosis of complement-mediated thrombotic microangiopathy/atypical hemolytic uremic syndrome
2025
Notes that diagnosis relies on clinical evaluations, ruling out mimics, and integrating functional/genetic testing.
Get citation
Cole, M. A. (2025). Update in the diagnosis of complement-mediated thrombotic microangiopathy/atypical hemolytic uremic syndrome. doi.org. https://doi.org/10.1182/hematology.2025000702

Clinical Spectrum and Differential Diagnosis of Adult Thrombotic Microangiopathies: Real-World Experience from a Tertiary Referral Center.
2026
Describes classifying patients into HUS and other subtypes based on clinical and laboratory evaluation.
Get citation
NP, K., G, O., S, D., F, C., & I, A. (2026). Clinical Spectrum and Differential Diagnosis of Adult Thrombotic Microangiopathies: Real-World Experience from a Tertiary Referral Center.. doi.org. https://doi.org/10.3390/hematolrep18040049

Systemic lupus erythematosus complicated by thrombotic microangiopathy with atypical HUS features: A case report.
2026
Utilizes laboratory investigations like elevated LDH, complement markers, and normal ADAMTS13 activity to diagnose SLE-associated aHUS.
Get citation
Y, L. & J, G. (2026). Systemic lupus erythematosus complicated by thrombotic microangiopathy with atypical HUS features: A case report.. doi.org. https://doi.org/10.1097/md.0000000000046412

Erythrodermic psoriasis complicated by immune complex-mediated crescentic glomerulonephritis and atypical hemolytic uremic syndrome: a case report.
2026
Combines clinical presentation, laboratory findings (thrombocytopenia, schistocytes, low C3), and renal biopsy to diagnose aHUS.
Get citation
X, C., J, H., Z, S., Q, Z., J, Y., & X, X. (2026). Erythrodermic psoriasis complicated by immune complex-mediated crescentic glomerulonephritis and atypical hemolytic uremic syndrome: a case report.. doi.org. https://doi.org/10.1186/s12882-026-04824-1

Early recognition of atypical hemolytic uremic syndrome to prevent irreversible kidney injury: cardiac failure and refractory hypertension as critical clues in young patients.
2026
Relies on laboratory markers including microangiopathic hemolytic anemia, thrombocytopenia, elevated LDH, and low C3 combined with biopsy to establish diagnosis.
Get citation
N, T., C, K., E, S., C, T., H, T., G, L., & A, K. (2026). Early recognition of atypical hemolytic uremic syndrome to prevent irreversible kidney injury: cardiac failure and refractory hypertension as critical clues in young patients.. doi.org. https://doi.org/10.1007/s13730-026-01100-x

What does the evidence say?

Multiple papers discuss the diagnostic criteria for atypical hemolytic uremic syndrome (aHUS), confirming that it is diagnosed using characteristic clinical presentations (such as organ injury and hypertension) and laboratory findings (such as microangiopathic hemolytic anemia, thrombocytopenia, elevated LDH, and complement abnormalities). No papers refute this claim.

Receipt History
first checked06 Aug 2026
judged → SUPPORTED · 8606 Aug 2026
Anyone with this link can read the claim and its public receipt, including any personal information in that text. Open permanent receipt.
Check your own claim
Challenge the receipt
Requests are recorded for review. This does not start an automatic check or guarantee a response time.

See the evidence timeline

Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.

This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work